Medicenna Therapeutics Corp. (MDNA.TO)
1.18
-0.20
(-14.49%)
CAD |
TSX |
Dec 11, 16:00
Medicenna Therapeutics EPS Diluted (Quarterly): -0.0585 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Zentek Ltd. | -0.0228 |
| Biocure Technology, Inc. | -0.0029 |
| Core One Labs, Inc. | -- |
| Restart Life Sciences Corp. | -0.0059 |
| NanoSphere Health Sciences, Inc. | -0.0013 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.883M |
| Total Expenses (Quarterly) | 4.883M |
| Enterprise Value | 99.51M |
| Earnings Yield | -14.36% |
| Normalized Earnings Yield | -19.33 |